髄膜炎菌ワクチンの世界市場2016-2020...市場調査レポートについてご紹介

【英文タイトル】Global Meningococcal Vaccines Market 2016-2020

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market overview
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights
• Key buying criteria

PART 05: Overview of vaccines
• Understanding Meningococcal disease
• Causes of meningococcal diseases
• Signs and symptoms
• Epidemiology
• Vaccine approval process

PART 06: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 07: Market segmentation by composition
• Mono vaccines
• Combination vaccines

PART 08: Geographical segmentation
• Global meningococcal vaccines market by geographical segmentation 2015-2020
• Meningococcal vaccines market in Americas
• Meningococcal vaccines market in US
• Meningococcal vaccines market in the Brazil
• Meningococcal vaccines market in EMEA
• Meningococcal vaccines market in Europe
• Meningococcal vaccines market in APAC
• Meningococcal vaccines market in Australia

PART 09: Market drivers
• Increase in awareness about vaccination and immunization programs
• Designated as a traveler’s vaccine
• Inclusion in national immunization schedule
• Threat of bioterrorism
• Additional age group approval

PART 10: Impact of drivers

PART 11: Market challenges
• Vaccine storage and handling issues
• High cost associated with vaccine development
• Stringent regulations
• Emergence of local players
• Adverse effects

PART 12: Impact of drivers and challenges

PART 13: Market trends
• Availability of combination vaccines
• Increase in strategic alliances and M&A
• Focus on emerging markets
• Public-private initiatives

PART 14: Vendor landscape
• Competitive scenario
• Market share analysis 2015
• Sanofi
• GlaxoSmithKline (GSK)
• Pfizer
• Other prominent vendors

PART 15: Appendix
• List of abbreviations

PART 16: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Key buying criteria for meningococcal vaccines
Exhibit 03: Distribution of meningococcal bacterial strains
Exhibit 04: Distribution of meningococcal bacterial strains in US
Exhibit 05: Distribution of meningococcal bacterial strains UK
Exhibit 06: Different type of bacterial causes of meningitis
Exhibit 07: Requirements for a BLA submission
Exhibit 08: Different types of development necessary to reach vaccine licensing stage
Exhibit 09: Vaccine development process over a period of up to 15 years at a cost of up to $1 billion
Exhibit 10: Regulatory testing of licensed vaccines
Exhibit 11: Pediatric/VFC meningococcal vaccine price list 2015
Exhibit 12: Price of adult meningococcal vaccine 2015
Exhibit 13: Global meningococcal vaccines market 2015-2020 ($ billions)
Exhibit 14: Five forces analysis
Exhibit 15: Global meningococcal vaccines market segmentation by composition
Exhibit 16: Global meningococcal vaccines market by composition 2015
Exhibit 17: Global meningococcal vaccines market by geography 2015
Exhibit 18: Global meningococcal vaccines market revenue by geography 2015-2020 ($ millions)
Exhibit 19: Percentage share of meningococcal vaccines market by geography 2015-2020
Exhibit 20: Global meningococcal vaccines market: YoY revenue and growth based on geography 2015-2020 ($ millions)
Exhibit 21: Meningococcal vaccines market in Americas 2015-2020 ($ billions)
Exhibit 22: Meningococcal vaccines market in America by country 2015
Exhibit 23: Meningococcal vaccines market in US 2015-2020 ($ billions)
Exhibit 24: Meningococcal vaccines market in Brazil 2015-2020 ($ millions)
Exhibit 25: Meningococcal vaccines market in EMEA 2015-2020 ($ millions)
Exhibit 26: Meningococcal vaccines market in EMEA by country 2015
Exhibit 27: Meningococcal vaccines market in Europe 2015-2020 ($ millions)
Exhibit 28: Meningococcal vaccines market in APAC 2015-2020 ($ millions)
Exhibit 29: Meningococcal vaccines market in APAC by country 2015
Exhibit 30: Meningococcal vaccines market in Australia 2015-2020 ($ millions)
Exhibit 31: Impact of drivers
Exhibit 32: A typical cold chain process
Exhibit 33: Impact of drivers and challenges
Exhibit 34: Overview of major vaccine related acquisitions (2005-2012)
Exhibit 35: Market share analysis of global meningococcal vaccines market 2015
Exhibit 36: Sanofi: YoY revenue growth of Meningitis/Pneumonia vaccines 2013-2015 ($ millions)
Exhibit 37: Geographical segmentation of meningitis/pneumococcal vaccines by revenue 2015
Exhibit 38: Sanofi: YoY revenue growth of Menactra 2013-2015 ($ millions)
Exhibit 39: Geographical segmentation of Menomune by revenue 2015
Exhibit 40: Key takeaways
Exhibit 41: Geographical segmentation of Bexsero by revenue 2015
Exhibit 42: Geographical segmentation of Menveo by revenue 2015
Exhibit 43: Key takeaways
Exhibit 44: Key takeaways


【レポート販売概要】

■ タイトル:髄膜炎菌ワクチンの世界市場2016-2020
■ 英文:Global Meningococcal Vaccines Market 2016-2020
■ 発行日:2016年7月18日
■ 調査会社:Technavio
■ 商品コード:IRTNTR9417
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。